Precise Alignment of Sites Required for μ Enhancer Activation in B Cells
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The lymphocyte-specific immunoglobulin mu heavy-chain gene intronic enhancer is regulated by multiple nuclear factors. The previously defined minimal enhancer containing the muA, muE3, and muB sites is transactivated by a combination of the ETS-domain proteins PU.1 and Ets-1 in nonlymphoid cells. The core GGAAs of the muA and muB sites are separated by 30 nucleotides, suggesting that ETS proteins bind to these sites from these same side of the DNA helix. We tested the necessity for appropriate spatial alignment of these elements by using mutated enhancers with altered spacings. A 4- or 10-bp insertion between muE3 and muB inactivated the mu enhancer in S194 plasma cells but did not affect in vitro binding of Ets-1, PU.1, or the muE3-binding protein TFE3, alone or in pairwise combinations. Circular permutation and phasing analyses demonstrated that PU.1 binding but not TFE3 or Ets-1 bends mu enhancer DNA toward the major groove. We propose that the requirement for precise spacing of the muA and muB elements is due in part to a directed DNA bend induced by PU.1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.
Karim, F. D., Urness, L. D., Thummel, C. S., Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., Maki, R. A., Gunther, C. V., & Nye, J. A. (1990) · Genes & Development · doi:10.1101/gad.4.9.1451 · Cited by 499 · cited 1×
“Both mA and mB sites contain the consensus element (GGA) for binding members of the ETS-domain family of transcription factors (25).”
BackgroundNye, J. A., Petersen, J. M., Gunther, C. V., Jonsen, M. D., & Graves, B. J. (1992) · Genes & Development · doi:10.1101/gad.6.6.975 · Cited by 363 · cited 2×
“Full-length Ets-1 contains two inhibitory domains, positioned immediately 59 or 39 to the ETS domain, that interfere with DNA-binding activity (18, 33, 43, 58); therefore, the DNA-binding ETS domain of Ets-1 [amino acids 325 to 426; referred to as ETS(Ets-1)] was used in these assays in lieu of the full-length protein.”
BackgroundMethodRegulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R. (1993) · Science · doi:10.1126/science.8316859 · Cited by 222 · cited 6×
“The minimal enhancer contains the mA and mB elements that bind ETS-domain proteins (42), along with the mE3 element that binds several factors belonging to the bHLH-zip family (3, 4, 7, 16, 48, 49).”
BackgroundMethodSelf-citationCooperative binding of Ets-1 and core binding factor to DNA.
Wotton, D., Ghysdael, J., Wang, S., Speck, N. A., & Owen, M. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.840 · Cited by 216 · cited 1×
“Finally, a close juxtaposition of core-binding factor sites to other sites has been noted in the TCR b- and d-chain gene enhancers (21, 60).”
BackgroundHagman, J., & Grosschedl, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8889 · Cited by 143 · cited 1×
“Full-length Ets-1 contains two inhibitory domains, positioned immediately 59 or 39 to the ETS domain, that interfere with DNA-binding activity (18, 33, 43, 58); therefore, the DNA-binding ETS domain of Ets-1 [amino acids 325 to 426; referred to as ETS(Ets-1)] was used in these assays in lieu of the full-length protein.”
MethodA novel modulator domain of Ets transcription factors.
Wasylyk, C., Kerckaert, J. P., & Wasylyk, B. (1992) · Genes & Development · doi:10.1101/gad.6.6.965 · Cited by 140 · cited 1×
“Full-length Ets-1 contains two inhibitory domains, positioned immediately 59 or 39 to the ETS domain, that interfere with DNA-binding activity (18, 33, 43, 58); therefore, the DNA-binding ETS domain of Ets-1 [amino acids 325 to 426; referred to as ETS(Ets-1)] was used in these assays in lieu of the full-length protein.”
MethodDNA binding by c‐Ets‐1, but not v‐Ets, is repressed by an intramolecular mechanism.
Lim, F., Kraut, N., Framptom, J., & Graf, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05096.x · Cited by 137 · cited 1×
“Full-length Ets-1 contains two inhibitory domains, positioned immediately 59 or 39 to the ETS domain, that interfere with DNA-binding activity (18, 33, 43, 58); therefore, the DNA-binding ETS domain of Ets-1 [amino acids 325 to 426; referred to as ETS(Ets-1)] was used in these assays in lieu of the full-length protein.”
Method
Cited by
Specificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Fisher, R. C., & Scott, E. W. (1998) · STEM CELLS · doi:10.1002/stem.160025 · Cited by 158
ETS Protein–Dependent Accessibility Changes at the Immunoglobulin μ Heavy Chain Enhancer
Nikolajczyk, B. S., Sanchez, J. A., & Sen, R. (1999) · Immunity · doi:10.1016/s1074-7613(00)80077-1 · Cited by 51
Self-citationPU.1 as a chromatin accessibility factor for immunoglobulin genes
Marecki, S., McCarthy, K. M., & Nikolajczyk, B. S. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.08.007 · Cited by 25
Self-citationMutants of ETS domain PU.1 and GGAA/T recognition: Free energies and kinetics
Pio, F., Assa‐Munt, N., Yguerabide, J., & Maki, R. A. (1999) · Protein Science · doi:10.1110/ps.8.10.2098 · Cited by 22
Metadata
- Authors
- Nikolajczyk, B. S., Nelsen, B., & Sen, R.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1996-08
- Volume
- 16
- Issue
- 8
- Pages
- 4544-4554
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2158263293
- Cited by
- 38
- References
- 7
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.